HeartSciences Inc. (HSCS) financial statements and ratios from SEC XBRL: revenue $4319.00 (TTM), net margin -211666.5%, revenue growth -0.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $4319.00 |
| Net Margin | -211666.5% |
| Return on Equity | -4044.0% |
| Current Ratio | 0.53 |
| Revenue Growth (YoY) | -0.7% |
| EPS Growth (YoY) | -62.7% |
| FCF Growth (YoY) | 0.2% |
| Price / Book | 36.57 |
| Price / Sales | 1900.44 |
| FCF Yield | -141.2% |
| Altman Z-Score | -27.49 (distress) |
| Sector P/E (Healthcare) | 21.6 |
HSCS overview · HSCS earnings · HSCS KPIs · HSCS investor relations · HSCS ownership · HSCS peers · HSCS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.